Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
991 GBX | +3.77% | +2.48% | -41.12% |
05-03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
05-01 | EXECUTIVE CHANGES: New chairs for CVS Group, LSL Property and Videndum | AN |
Sales 2024 * | 672M 846M 1.15B | Sales 2025 * | 720M 906M 1.24B | Capitalization | 711M 895M 1.22B |
---|---|---|---|---|---|
Net income 2024 * | 43M 54.13M 73.88M | Net income 2025 * | 52M 65.46M 89.34M | EV / Sales 2024 * | 1.38 x |
Net Debt 2024 * | 219M 276M 376M | Net Debt 2025 * | 174M 219M 298M | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
13.6
x | Employees | 9,100 |
Yield 2024 * |
0.8% | Yield 2025 * |
0.86% | Free-Float | 98.44% |
Latest transcript on CVS Group plc
1 day | +3.77% | ||
1 week | +2.48% | ||
Current month | +1.23% | ||
1 month | +5.88% | ||
3 months | -40.69% | ||
6 months | -37.28% | ||
Current year | -41.12% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 19-11-05 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Kemp
BRD | Director/Board Member | 62 | 18-01-01 |
David Wilton
CHM | Chairman | 61 | 21-09-23 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | -.--% | ||
0.04% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 991 | +3.77% | 424,623 |
24-05-13 | 955 | -2.85% | 552,899 |
24-05-10 | 983 | +0.51% | 191,667 |
24-05-09 | 978 | -0.61% | 209,318 |
24-05-08 | 984 | +1.76% | 374,734 |
Delayed Quote London S.E., May 14, 2024 at 11:35 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.12% | 860M | |
-27.02% | 137M |
- Stock Market
- Equities
- CVSG Stock